ClinConnect ClinConnect Logo
Search / Trial NCT05675878

Confirmation of Diet as a Treatment for Gulf War Illness

Launched by AMERICAN UNIVERSITY · Jan 5, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Gulf War Illness Gwi Gulf War Syndrome Diet Treatment

ClinConnect Summary

This clinical trial is looking at whether a specific diet can help improve symptoms of Gulf War Illness in veterans. Previous smaller studies showed that participants who followed this diet felt significantly better after just one month. The researchers want to confirm these findings with a larger group of veterans and explore how this diet might affect the nervous system. They will also check for changes in blood markers that could indicate improvement after following the diet.

To participate, you need to be a veteran who served in the Gulf War (1990-1991) and be 75 years old or younger. You'll need to meet certain health criteria, including being stable on your medications for at least a month. During the study, participants will be randomly assigned to either follow the diet or be in a wait-list control group for one month, after which they will be reassessed to see how they did. If you're interested in a potential new way to feel better and meet the eligibility criteria, this study could be a great opportunity!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Males and Females of all races and ethnicities who are ≤75 yrs of age
  • Served in the 1990-1991 Persian Gulf War
  • Fulfill both Center for Disease Control (CDC) and Kansas definitions of Gulf War Illness
  • Stable medication regimen for ≥1 month and willing to keep medications and supplements stable throughout study participation
  • Exclusion Criteria:
  • Recent substance use disorder (past year)
  • Unwilling to stop using alcohol, tobacco (including vaping) and/or marijuana; or unwilling to change diet
  • Diagnosed seizure disorder or severe asthma requiring past hospitalization
  • Currently taking medication which affects glutamatergic or GABAergic neurotransmission (but can work with their physician to wean off of these medications prior to participating)

About American University

American University is a distinguished institution recognized for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its robust interdisciplinary expertise and state-of-the-art facilities to advance healthcare knowledge and improve patient outcomes. Through rigorous research methodologies and collaboration with leading experts, American University aims to contribute significantly to the fields of medicine and public health, ensuring that its trials adhere to the highest ethical standards and regulatory requirements. The university fosters an environment that encourages exploration and discovery, ultimately enhancing the well-being of diverse communities.

Locations

Boston, Massachusetts, United States

Fort Lauderdale, Florida, United States

Washington, District Of Columbia, United States

Patients applied

0 patients applied

Trial Officials

Kathleen F Holton, PhD, MPH

Principal Investigator

American University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials